Inhibitor of hematopoietic pluripotent stem cell proliferation: purification and determination of its structure
- PMID: 2915977
- PMCID: PMC286560
- DOI: 10.1073/pnas.86.3.779
Inhibitor of hematopoietic pluripotent stem cell proliferation: purification and determination of its structure
Abstract
We report here a five-step purification procedure that led to the isolation from fetal calf bone marrow extract of a tetrapeptide, Ac-Ser-Asp-Lys-Pro (Mr 487), exerting a high inhibitory activity on the proliferation of hematopoietic pluripotent stem cells [defined here as spleen colony-forming units (CFU-S)]. The structure of this molecule was established from amino acid analysis, fast atom bombardment mass spectrometry, and 1H nuclear magnetic resonance spectral data. This structure was confirmed by comparison with the corresponding synthetic molecule, which presents identical physiochemical characteristics and biological properties. Natural and synthetic peptides administered to mice (at a dose of 100 ng per mouse) after one injection of cytosine arabinonucleoside prevent CFU-S recruitment into DNA synthesis.
Similar articles
-
Human placental low molecular weight factors inhibit the entry into cell cycle of murine pluripotent stem cells.Leukemia. 1991 Mar;5(3):270-2. Leukemia. 1991. PMID: 2013983
-
Activated granulocytes oxidize the endogenous stem cell inhibitory peptide pGlu-Glu-Asp-Cys-Lys (pEEDCK) to the stimulatory dimer: a redox-mediated mechanism for demand-induced hematopoietic regulation.Exp Hematol. 1998 Aug;26(9):851-8. Exp Hematol. 1998. PMID: 9694506
-
A low-molecular-weight factor extracted from human placenta inhibits the entry into cell cycle of murine pluripotent stem cells.Ann N Y Acad Sci. 1991;628:169-71. doi: 10.1111/j.1749-6632.1991.tb17237.x. Ann N Y Acad Sci. 1991. PMID: 2069297 No abstract available.
-
Stem cell proliferation inhibitors.Baillieres Clin Haematol. 1992 Jul;5(3):723-39. doi: 10.1016/s0950-3536(11)80014-4. Baillieres Clin Haematol. 1992. PMID: 1457966 Review. No abstract available.
-
Cytosine arabinoside: molecular, pharmacokinetic and cytokinetic considerations.Pharmacol Ther. 1984;25(2):207-38. doi: 10.1016/0163-7258(84)90044-5. Pharmacol Ther. 1984. PMID: 6390467 Review. No abstract available.
Cited by
-
The Role of Tβ4-POP-Ac-SDKP Axis in Organ Fibrosis.Int J Mol Sci. 2022 Oct 31;23(21):13282. doi: 10.3390/ijms232113282. Int J Mol Sci. 2022. PMID: 36362069 Free PMC article. Review.
-
Prolyl oligopeptidase is involved in release of the antifibrotic peptide Ac-SDKP.Hypertension. 2004 May;43(5):1140-5. doi: 10.1161/01.HYP.0000126172.01673.84. Epub 2004 Mar 22. Hypertension. 2004. PMID: 15037553 Free PMC article.
-
Ac-SDKP reverses cardiac fibrosis in rats with renovascular hypertension.Hypertension. 2003 Dec;42(6):1164-70. doi: 10.1161/01.HYP.0000100423.24330.96. Epub 2003 Oct 27. Hypertension. 2003. PMID: 14581293 Free PMC article.
-
Distribution and biological activity ofβ-thymosins.Amino Acids. 1994 Feb;6(1):1-13. doi: 10.1007/BF00808118. Amino Acids. 1994. PMID: 24190738
-
N-Acetyl-seryl-aspartyl-lysyl-proline Alleviates Renal Fibrosis Induced by Unilateral Ureteric Obstruction in BALB/C Mice.Mediators Inflamm. 2015;2015:283123. doi: 10.1155/2015/283123. Epub 2015 Oct 5. Mediators Inflamm. 2015. PMID: 26508815 Free PMC article.
References
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
Molecular Biology Databases